Authors
R Pasquali, F Casanueva, M Haluzik, L van Hulsteijn, S Ledoux, M P Monteiro, J Salvador, F Santini, H Toplak, O M Dekkers
Developed By:
The European Society of Endocrinology, including representatives from the European Association of the Study of Obesity (EASO).
Introduction
Obesity is an emerging condition, with a prevalence of ~20%. Although the simple measurement of BMI is likely a simplistic approach to obesity, BMI is easily calculated, and there are currently no data showing that more sophisticated methods are more useful to guide the endocrine work-up in obesity. An increased BMI leads to a number of hormonal changes. Additionally, concomitant hormonal diseases can be present in obesity and have to be properly diagnosed – which in turn might be more difficult due to alterations caused by body fatness itself. The present European Society of Endocrinology Clinical Guideline on the Endocrine Work-up in Obesity acknowledges the increased prevalence of many endocrine conditions in obesity.
This guideline was developed for healthcare providers involved in the care of patients with obesity, which covers a broad range of doctors. In line, the guidelines were not developed with the specific aim to cover rare forms of obesity.
Related Resources
Additional resources were also made available.
01/01/2020